Case-Study: Outlining Safety Packages for Specific Bioactive Ingredients to Lay Down a Regulatory Framework & Product Timeline Horizons

Time: 9:00 am
day: Day Two


  • Discussing how to curate a robust safety package from pre-clinic and clinic to regulators to streamline ingredient approval
  • Understanding what a bioactive compound from a regulatory perspective is to speak to and diffuse objections
  • Setting up a framework for approval as an ingredient provider to assess and eradicate risk ahead of time when working with unapproved bioactives¬†